Next 10 |
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC PINK:GSTC). This announcement is effective immediately and the market effective ...
Srinivasan's medical management experience, leadership positions, and advisory experience will add additional depth to the AngioSoma team. RICHLAND, WA / ACCESSWIRE / July 1, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Kaushik Srinivasan, CEO, Radiant Health, to the Advisory Board....
Dr. Lewis's medical experience and research background will play a significant role in AngioSoma. RICHLAND, WA / ACCESSWIRE / June 22, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Dr. Michael Lewis, MD, to the Medical Advisory Board. Dr. Lewis's experience in frontier sciences, pati...
Chicoski brings decades of robust financial experience to the AngioSoma management team RICHLAND, WA / ACCESSWIRE / May 12, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Robert Chicoski as its Chief Financial Officer and Treasurer. Chicoski has decades of corporate financial, tax, au...
Morris' economic, strategic, and market intellingence experience will play a key role in the growth of AngioSoma. RICHLAND, WA / ACCESSWIRE / May 11, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Darryl Morris as a Strategic Economic Advisor. Morris has over three decades of economic...
Dr. Wisneski's medical and teaching experience will play a key role in the growth of AngioSoma. RICHLAND, WA / ACCESSWIRE / May 4, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Dr. Leonard Wisneski, MD, FACP as the Chair of the Medical Advisory Board. Dr. Wisneski's experience in fro...
Penderghast's Experience Medical Sciences Will Play a Key Role in the Growth of AngioSoma RICHLAND, WA / ACCESSWIRE / April 21 / 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Steven F. Penderghast to its Board of Directors. Penderghast has experience working in medical sciences, as w...
AngioSoma (SOAN) appoints David Croom as the company's new executive vice president to oversee both operations and sales.The company statement, "Leveraging 30+ years of experience in both large and small companies gives Croom a unique perspective with respect to the regulatory, financial...
Croom's Experience in Finance, Sales, and Operations Will Play a Key Role in the Growth of AngioSoma RICHLAND, WA / ACCESSWIRE / April 20, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has hired David Croom as an Executive Vice President. Mr. Croom brings decades of experience in finance, sale...
AngioSoma (SOAN) announces the appointment of Brooke Greenwald as the company's Chief Marketing Officer.Greenwald has more than three decades of experience in marketing and public relations, and has held leadership positions in multiple healthcare organizations and is an a...
News, Short Squeeze, Breakout and More Instantly...
First Titan Company Name:
SOAN Stock Symbol:
OTCMKTS Market:
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC PINK:GSTC). This announcement is effective immediately and the market effective ...
Srinivasan's medical management experience, leadership positions, and advisory experience will add additional depth to the AngioSoma team. RICHLAND, WA / ACCESSWIRE / July 1, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Kaushik Srinivasan, CEO, Radiant Health, to the Advisory Board....
Dr. Lewis's medical experience and research background will play a significant role in AngioSoma. RICHLAND, WA / ACCESSWIRE / June 22, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Dr. Michael Lewis, MD, to the Medical Advisory Board. Dr. Lewis's experience in frontier sciences, pati...